Price T Rowe Associates Inc Boston Scientific Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 8,251,379 shares of BSX stock, worth $738 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
8,251,379
Previous 8,071,053 2.23%
Holding current value
$738 Million
Previous $622 Million 11.25%
% of portfolio
0.08%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$72.96 - $84.0 $13.2 Million - $15.1 Million
180,326 Added 2.23%
8,251,379 $691 Million
Q2 2024

Aug 14, 2024
BUY
$67.33 - $77.71 $59.8 Million - $69.1 Million
888,893 Added 12.38%
8,071,053 $622 Million
Q1 2024

May 15, 2024
BUY
$57.6 - $68.62 $50.6 Million - $60.3 Million
878,404 Added 13.93%
7,182,160 $492 Million
Q4 2023

Feb 14, 2024
BUY
$48.64 - $57.81 $25.1 Million - $29.9 Million
516,386 Added 8.92%
6,303,756 $364 Million
Q3 2023

Nov 14, 2023
BUY
$50.19 - $54.68 $60 Million - $65.4 Million
1,195,590 Added 26.04%
5,787,370 $306 Million
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $27.9 Million - $30.6 Million
560,880 Added 13.91%
4,591,780 $248 Million
Q1 2023

May 15, 2023
BUY
$45.09 - $50.03 $75 Million - $83.2 Million
1,663,351 Added 70.26%
4,030,900 $202 Million
Q4 2022

Feb 14, 2023
BUY
$39.56 - $47.22 $20.5 Million - $24.4 Million
517,236 Added 27.95%
2,367,549 $110 Million
Q3 2022

Nov 14, 2022
BUY
$36.71 - $109.66 $284,061 - $848,549
7,738 Added 0.42%
1,850,313 $71.7 Million
Q2 2022

Aug 15, 2022
SELL
$35.24 - $47.1 $6.87 Million - $9.18 Million
-194,886 Reduced 9.57%
1,842,575 $68.7 Million
Q1 2022

May 16, 2022
SELL
$40.9 - $45.1 $155 Million - $170 Million
-3,778,489 Reduced 64.97%
2,037,461 $90.2 Million
Q4 2021

Feb 14, 2022
SELL
$38.07 - $44.87 $735,855 - $867,292
-19,329 Reduced 0.33%
5,815,950 $247 Million
Q3 2021

Nov 15, 2021
SELL
$41.23 - $45.88 $16.1 Million - $17.9 Million
-390,328 Reduced 6.27%
5,835,279 $253 Million
Q2 2021

Aug 16, 2021
SELL
$38.58 - $44.24 $11.2 Million - $12.8 Million
-289,028 Reduced 4.44%
6,225,607 $266 Million
Q1 2021

May 17, 2021
SELL
$35.27 - $39.67 $273 Million - $307 Million
-7,747,002 Reduced 54.32%
6,514,635 $252 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $41.97 $473 Million - $599 Million
14,261,637 New
14,261,637 $513 Million

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $128B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email